Maravai LifeSciences Holdings, Inc.
MRVI
$2.67
$0.020.76%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -11.76% | -10.30% | -33.99% | -48.78% | -61.81% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -11.76% | -10.30% | -33.99% | -48.78% | -61.81% |
| Cost of Revenue | -1.13% | 1.43% | -10.99% | -11.86% | -5.66% |
| Gross Profit | -25.28% | -22.75% | -49.18% | -65.33% | -78.26% |
| SG&A Expenses | 7.32% | 9.83% | 5.65% | 11.65% | 14.27% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.15% | 5.92% | -4.53% | -2.31% | 2.24% |
| Operating Income | -90.18% | -198.27% | -156.16% | -120.45% | -111.64% |
| Income Before Tax | -148.64% | -142.33% | 668.30% | 210.97% | 57.81% |
| Income Tax Expenses | -100.26% | -100.25% | 47,572.98% | 4,123.28% | 1,917.25% |
| Earnings from Continuing Operations | -81.45% | -87.62% | -647.31% | -193.36% | -146.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 343.30% | 493.28% | 385.59% | 130.70% | 115.15% |
| Net Income | -24.17% | -21.69% | -1,014.59% | -274.96% | -185.49% |
| EBIT | -90.18% | -198.27% | -156.16% | -120.45% | -111.64% |
| EBITDA | -920.10% | -252.96% | -99.13% | -99.17% | -100.89% |
| EPS Basic | -15.81% | -14.44% | -982.55% | -273.90% | -185.12% |
| Normalized Basic EPS | -86.96% | -87.55% | 80,834.09% | 1,968.14% | 804.58% |
| EPS Diluted | -15.73% | -14.36% | -987.51% | -274.13% | -185.73% |
| Normalized Diluted EPS | -86.96% | -87.55% | 80,834.09% | 1,969.53% | 1,067.73% |
| Average Basic Shares Outstanding | 6.51% | 4.52% | 2.79% | 1.04% | 0.35% |
| Average Diluted Shares Outstanding | 6.51% | 4.52% | 2.79% | 1.01% | -18.78% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |